datetime,headline,summary,related,lang,source
2020-12-09 11:55:14-05:00,"Apheresis Market 2020 Major Key Companies – Asahi Kasei Medical Co. Ltd., Fresenius Medical Care, Terumo BCT, Inc., Haemonetics Corporation Forecast 2023","Market Scenario The global apheresis market is presumed to register 10.2 % CAGR during the forecast period (2017-2023), owing to the increasing prevalence of chronic renal diseases, asserts Market Research Future (MRFR). Apheresis is referred to as the procedure of separating",HAE,en,OpenPR
2020-11-06 11:37:38-05:00,"Global Therapeutic Plasma Exchange Market Analysis of Emerging Key Vendors Such as Terumo BCT, Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc. and many more.","InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global Therapeutic Plasma Exchange Market Assessment – Revenue (US$ Mn) Forecast Till 2028” Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-therapeutic-plasma-exchange-market-assessment/ According to the latest research by InsightAce Analytic, the global",HAE,en,OpenPR
2020-11-06 09:15:05-05:00,"Autotransfusion Device Market Is Projected To Reach US$ 1,270.67 Million By 2027 With Top Players Like Medtronic, Fresenius SE & Co. KGaA, Teleflex Incorporated, BD, Zimmer Biomet, Braile Biomedica, Haemonetics Corporation, SARSTEDT AG","A new research document with title Global Autotransfusion Device Market Report covering detailed analysis, Competitive landscape, forecast and strategies has been added to the Insight Partners. The study covers geographic analysis that includes regions like North America, Europe and Asia-Pacific,",HAE,en,OpenPR
2020-11-04 06:00:00-05:00,Haemonetics 2nd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website,"BOSTON, Nov. 4, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its second quarter fiscal 2021, which ended September 26, 2020, are available on its Investor Relations website. In addition, the Company is also posting the earnings release and…",HAE,en,PR Newswire
2020-10-16 03:40:01-05:00,"Apheresis Market Size To Reach USD 4.20 Billion, Globally, By 2023 | Haemonetics Corporation, Fresenius Kabi","UPDATE AVAILABLE ON-DEMAND According to the report by Allied Market Research, the global apheresis market is estimated to register a CAGR of 7.3% from 2017 to 2023. The research helps leading players and startups to devise new strategies based on current",HAE,en,OpenPR
2020-09-09 15:53:00-05:00,Haemonetics To Present At The 18th Annual Morgan Stanley Global Healthcare Conference,"BOSTON, Sept. 9, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 18th Annual Morgan Stanley Virtual Global Healthcare Conference on Tuesday, Sept. 15, 2020, at 9:30 a.m. ET. The public may access Mr. Simon's…",HAE,en,PR Newswire
2020-08-04 05:00:00-05:00,Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor Relations Website,"BOSTON, Aug. 4, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter fiscal 2021, which ended June 27, 2020, are available on its Investor Relations website. In addition, the Company is also posting the earnings release and results…",HAE,en,PR Newswire
2020-08-02 10:08:50-05:00,"The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings","Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in, with big pharma tie-ups flaunting positive tidings. In the biggest ever coronavirus funding deal, the Sanofi SA (NASDAQ: SNY ) GlaxoSmithKline plc (NYSE: GSK ) won a joint $2.1 billion U.S. federal funding award. Here're the key catalysts for the unfolding week: Conferences 72nd National Hemophilia Foundation's Annual Bleeding Disorders Meeting 2020 (virtual meeting): Aug. 1-8 PDUFA Dates FDA is scheduled to rule on DBV TECHNOLOGIE/S' ADR (NASDAQ: DBVT ) Viaskin peanut allergy patch Wednesday. However, cancellation of the Adcom meeting scheduled May 15 has poured cold water on the prospects of an approval coming through. Trevena Inc (NASDAQ: TRVN ) has a tryst with the FDA Friday, with respect to the NDA for its pain drug oleceridine, which was once rejected by the agency on the premise of inadequacy of clinical data.",HAE,en,Benzinga
2020-06-25 14:00:00-05:00,M1 Kliniken: Sprung in neue Dimensionen,"Durch das Einbringen von Haemato wächst der Umsatz beim Schönheitskonzern M1 Kliniken um ein Vielfaches. Von Georg Pröbstl, Euro am Sonntag",HAE,de,BORSE ONLINE
2020-06-22 11:16:16-05:00,High school staff make visors for new cancer hospital | On The Spot (OTS) News Southport,"Face visors designed and made in a local high school are being donated for use in Liverpool’s first dedicated cancer hospital. The face visors, designed to be worn as PPE (personal protective equipment) against the spread of COVID-19 (coronavirus) and other infectious diseases, have been donated to frontline NHS workers in the new haemato-oncology ward at […]",HAE,en,OTS NEWS.co.uk
2020-05-27 03:03:10-05:00,HAEMATO : AGM postponement | MarketScreener,"Due to the present imponderables HAEMATO AG will reschedule the Annual General Meeting originally intended on July 8, 2020 to a later date. Due to the current… | May 27, 2020",HAE,en,MarketScreener
2020-05-05 05:00:00-05:00,Haemonetics 4th Quarter and Fiscal 2020 Earnings Release Available on Investor Relations Website,"BOSTON, May 5, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its fourth quarter and fiscal 2020, which ended March 28, 2020, are available on its Investor Relations website. In addition, the Company is also posting the earnings release and…",HAE,en,PR Newswire
2020-05-03 07:45:37-05:00,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,"Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK ) and Pfizer Inc. (NYSE: PFE ). Merck disappointed by lowering its outlook, although sell-side stayed positive on the prospects. Presentations at the American Association of Cancer Research Virtual Conference created some volatility. Verastem Inc (NASDAQ: VSTM ) became a casualty of ""not-so-impressive"" clinical data on its Phase 1 asset VS-6766 that targets KRAS mutant advanced solid tumors. The stock shed about 57% to a low of $1.77 before recovering some lost ground. Here are the key catalysts for the unfolding week. Conferences SunTrust Robinson Humphrey 6th Annual Life Sciences Summit (Virtual Conference): May 5–6 Maxim Group M-Vest Infectious Disease Virtual Conference: May 5 Related Link: A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio Clinical Readouts Adverum Biotechnologies Inc (NASDAQ: ADVM ) is scheduled to present new data from the OPTIC Phase1 clinical trial of ADVM-022 intravitreal gene therapy in wet age-related macular degeneration.",HAE,en,Benzinga
2020-03-19 06:37:15-05:00,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.","HAE,HALO",en,Benzinga
2020-01-14 06:30:00-05:00,Haemonetics Announces Acquisition Of Intellectual Property Assets Relating To TEG® 6s Hemostasis Analyzer System,"BOSTON, Jan. 14, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that it has purchased the technology underlying the TEG® 6s Hemostasis…",HAE,en,PR Newswire
2019-12-19 16:10:00-05:00,"Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2020 Results: February 4, 2020","BOSTON, Dec. 19, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2020 financial results at 6:00 am EDT on Tuesday, February 4, 2020. The Company will hold a conference call with investors and analysts to…",HAE,en,PR Newswire
2019-11-16 10:40:29-05:00,Said Bolorforosh Sells 339 Shares of Haemonetics Co. (NYSE:HAE) Stock,"Haemonetics Co. (NYSE:HAE) EVP Said Bolorforosh sold 339 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $118.27, for a total value of $40,093.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available […]",HAE,en,Modern Readers
2019-11-01 05:00:00-05:00,Haemonetics 2nd Quarter and First Half Fiscal 2020 Earnings Release Available on Investor Relations Website,"BRAINTREE, Mass., Nov. 1, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter and first half of fiscal 2020, which ended Sept. 28, 2019, are available on its Investor Relations website. The Company is posting the earnings…",HAE,en,PR Newswire
2019-07-25 06:21:54-05:00,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 24) Acasti Pharma Inc (NASDAQ: ACST ) Cardiovascular Systems Inc (NASDAQ: CSII ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Masimo Corporation (NASDAQ: MASI ) VolitionRX Ltd (NYSE: VNRX ) Edwards Lifesciences Corp (NYSE: EW )(reported a beat-and-raise second quarter) Haemonetics Corporation (NYSE: HAE ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 24) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) GENFIT S A/ADR (NASDAQ: GNFT ) ContraVir Pharmaceuticals Inc (NASDAQ: HEPA) Innoviva Inc (NASDAQ: INVA ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS ) Neovasc Inc (NASDAQ: NVCN ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Pluristem Therapeutics Inc. (NASDAQ: PSTI )(announced 1-for-10 reverse stock split) Regulus Therapeutics Inc (NASDAQ: RGLS )(FDA imposed partial clinical hold on its kidney disease drug) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Wave Life Sciences Ltd (NASDAQ: WVE ) Stocks In Focus FDA Approves Lilly's Nasally-Administered Low Blood Sugar Drug Eli Lilly And Co (NYSE: LLY ) said the FDA has approved its Baqsimi, the first and only nasally administered glucagon to treat severe hypoglycemia in a single, fixed, 3mg dose.",HAE,en,Benzinga
